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1. Introduction 
Analytical isotachophoresis in a capillary tube is a 
highly potent tool for the separation of compounds 
exhibiting very small differences in net electrophoretic 
mobility. The basic principles of isotachophoresis 
have been previously described by several authors 
[l-3]. 
It was anticipated, that upon complex formation 
of a protein and a drug, it should be possible to 
distinguish between the complex and the native 
protein by using analytical isotachophoresis. Further- 
more, this method seemed feasible for separating and 
quantitating the non-complexed drug. 
The interacting system studied in this work is 
composed of the protein human serum albumin (HSA) 
and the anti-inflammatory drug indomethacin [ l-(p- 
chlorobenzoyl)-5-methoxy-2-methyl-indole-3-acetic 
acid]. This drug is frequently used for the treatment 
of rheumatic diseases. The molecular formula is 
shown in fig. 1. 
The binding of indomethacin (I) to human plasma 
has been studied by Hvidberg et al. [4] , who found 
Fig.1. Molecular formula of the drug mdomethacin. 
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fifteen binding sites for the drug, all of which were 
proposed to be located on the albumin molecule. 
However, depending on the experimental technique 
used, Hultmark et al. [5] found indomethacin to bind 
to four or five binding sites on the HSA-molecule. 
The HSA-I system was chosen for this first 
approach of using analytical isotachophoresis in 
protein-drug complex formation studies, since it is 
a relatively-well studied system involving a strongly 
protein-bound drug. 
2. Materials and methods 
The human serum albumin and indomethacin were 
obtained from AB Kabi, Stockholm and A.-S. 
Dumex, Copenhagen, respectively. The protein was 
dissolved in distilled water to a concentration of 
85 pg/pl (1.3 nmol/pl). Indomethacin was dissolved 
in the leading electrolyte (see below) to a concentra- 
tion of 0.65 pg/pl (1.8 nmol/pl). 
Incubation mixtures were prepared from these 
two stock solutions according to table 1. The samples 
were incubated at ambient temperature for one hour 
before analysis. 
The analyses were performed with a LKB 2127 
Tachophor (LKB-Produkter AB, Sweden) equipped 
with a 23 cm capillary tubing. The leading electrolyte 
was 5 mM HCI, 10 mM 2-amino-2-methyl-l,3- 
propanediol (ammediol, Sigma Chem. Co., USA) with 
a 0.4%, HPMC (hydroxypropylmethylcellulose. 
Methocel90 HG, 15 000 cps, Dow Chem. Co., USA), 
pH 9.0. Chloride acts as the leading ion and ammediol 
as the counter ion, and HPMC was added to counter- 
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Table 1 
Composition of incubated samples 
August 1978 
Sample Volume Volume Volume Injected Injected amount of Molar ratio 
(Refers to albumin indomethacin buffer volume Albumin Indomethacin of albumin to 
fig.3) solution solution (Pl) W) indomethacin 
(Pl) (Pl) (nmol) kg) (nmol) (pg) (HSA:I) 
a 50 25 175 5 
b 50 50 150 5 
C 50 100 100 5 
d 50 200 _ 5 
Esperimental details are given in section 2 
act electroendosmosis. The terminating electrolyte 
was 5 mM e-aminocaproic acid (Roth, Karlsruhe) 
adjusted to a pH of about 10.5 with freshly made 
Ba(OH)2 solution (Merck, FRG). The separations 
were performed at 12°C with a constant current of 
initially 170 E.IA and of 68 PA during detection. 
Due to the high W-absorptivity of the protein as 
well as of the drug, the standard W-detector 
(254 nm) was used. The samples were injected in 
volumes of 2.5 or 5 pl. 
3. Results and discussion 
Figure 2 illustrates the W-profiles obtained from 
the analyses of the individual components of the 
uv 
254 nm 
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Fig.2. lJV-profiles from the isotachophoretic analysis of 
albumin (tig.a) and indomethacin (Iig.b) respectively. 
Experimental details are given in section 2. The injected 
amounts were 210 pg and 0.81 j&g of albumin and indo- 
methacin, respectively. 
1.3 85 0.9 0.33 110.7 
1.3 85 1.8 0.65 1 1.4 
1.3 85 3.6 1.3 1 : 2.8 
1.3 85 7.2 2.6 1 : 5.5 
incubation mixtures. It is evident that a very pure 
preparation of HSA was used, as indicated by the 
homogeneity and the very sharp zone boundaries 
(fig.2a). Furthermore, indomethacin with its 
strongly W-absorbing chromophore appears as a 
homogeneous and well-defined W-profile (fig.2b). 
The small UV-absorbing spikes, as well as the 
shoulder on the indomethacin peak, were also observed 
when analyzing a ‘blank’. Consequently, they were 
ascribed to impurities in the electrolyte system. From 
this figure, it can also be concluded that indomethacin 
gives a higher W-absorptivity than albumin at iso- 
tachophoretic concentrations under the experimental 
conditions used. 
The titration of the binding sites on HSA with 
indomethacin is illustrated in fig.3. It should be 
stressed that, in isotachophoretic analysis, the zone- 
width and not the zone-height reflects the amount of 
material in each zone. Comparing the zones mutually 
and to the zone of free albumin in fig.2a (1.3 and 
3.3 nmol respectively was injected), it is evident that 
the relative zone-width changes during the titration. 
This may reflect a change in net electrophoretic 
mobility when the drug binds to the albumin molecule. 
However, the significant feature of these W-profiles 
is the increase in peak-height when increasing the 
amount of indomethacin. This reflects the difference 
beween the W-absorptivity of HSA alone and that of 
the complex of HSA-I,, where 12 indicates the relative 
molar amount of bound indomethacin. Furthermore, 
it is evident that no or very small amounts of free 
indomethacin are present in the first three samples. 
It is concluded that, for these molar ratios, the 
binding of the drug to the protein is practically 
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Fig.3. UV-profiles from the isotachophoretic analysis of 
incubation mixtures containing various ratios of albumin to 
indomethacin. Experimental details are given in section 2. 
Ratio of albumin to indomethacin: 1:0.7 (a), 1:1.4 (b), 1:2.8 
(c). and 1:5.5 (d). 
stoichiometric, i.e. n equals 0.7, 1.4 and 2.8, 
respectively. However, when reaching a molar ratio 
of 1:5.5 (HSA:I) a sharp indomethacin zone appears, 
indicating that the albumin is saturated with bound 
indomethacin (fig.3d). By measuring the width of the 
indomethacin zone, the molar amount can be cal- 
culated from a pre-made calibration curve. In this 
case, the zone-width corresponds to 2.2 nmol indo- 
methacin. Since the total amount of indomethacin 
added was 7.2 nmol (table l), the amount of bound 
indomethacin is 5.0 nmol. The saturation ratio can 
now be calculated to be 1.3:5.0 which equals 1:3.9, 
indicating the binding of four indomethacin 
molecules to each molecule of albumin. However, the 
curved W profile of the saturated albumin complex 
(fig.3d) may indicate a lower binding strength for the 
fourth indomethacin. 
It is concluded that analytical isotachophoresis in 
a capillary tube, due to the very high resolution of 
the technique in combination with the possibility of 
quantitation, is a powerful tool for studying strong 
complex-formation systems, such as the protein- 
drug interaction studied in this work. Also in protein- 
protein interaction systems, it is possible to separate 
the complex from the constituent protein com- 
ponents. This was indicated by our preliminary studies 
on tryptic fragments of the staphylococcal protein A 
in its interaction with the Fc-fragment of immuno- 
globulin G. Furthermore, by thorough theoretical 
considerations of the shape of the W-profile 
representing the complex, it should also be possible 
to study weakly-interacting systems, in which the 
complexes are disrupted during the separation. Such 
kinetically labile complex equilibria have been used 
in capillary isotachophoresis to increase the separat- 
ing power of this technique [6] . 
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